Better Choice Company Inc. (BTTR) Q3 2024 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call summary highlights strong financial performance, including significant sales growth and a positive adjusted EBITDA for the first time in years. Strategic initiatives such as the acquisition of SRx Health and operational improvements are expected to drive future growth. Despite competitive pressures and regulatory risks, the company's focus on profitability and cash generation is promising. The lack of significant concerns in the Q&A session further supports a positive sentiment. The recent public offering may slightly temper the reaction, but overall, a positive stock price movement is anticipated.
Key Financial Performance
Revenue $11.4 million, a 33% quarter-over-quarter growth, primarily driven by a 92% growth in Asia-Pacific sales.
Gross Margin 40%, improved by 600 basis points year-over-year due to favorable terms on co-supply agreements.
Adjusted EBITDA Just over $200,000, a 255% year-over-year growth, marking the company's first profitable quarter in over four years.
Net Income $1.5 million for Q3, with earnings per share of $0.74.
Net Working Capital $9.5 million, compared to $3.1 million last quarter, reflecting a focus on rightsizing the business.
Free Cash Flow Improved free cash flow, with a 700 basis point improvement in adjusted EBITDA margin year-over-year.
Sales for Nine-Month Period $28 million, compared to $33 million in the same period last year, due to strategic exit from unprofitable channels.
Operating Highlights
International Sales Growth: In our International channel, we generated 9% year-over-year growth, with particularly strong performance across our Asia-Pacific customers.
Asia-Pacific Market Opportunity: We believe this demographic shift represents a tremendous opportunity to expand our footprint in one of the largest and fastest-growing pet food markets globally.
Sales Growth: We generated 33% quarter-over-quarter sales growth to $11.4 million.
Gross Margin Improvement: Improved gross margin for the third consecutive quarter to 40%.
Inventory Reduction: Reduced inventory by 48% year-over-year.
Operational Efficiency: Achieved average fill rates of 97%.
Adjusted EBITDA: Achieved the company's first profitable quarter in years at just north of $200,000 of adjusted EBITDA.
Acquisition of SRx Health: We're in the process of completing our acquisition of SRx Health, which will position Better Choice as a leading global health and wellness company.
Strategic Exit from Unprofitable Channels: We expect that the year-over-year consolidated sales decline as we strategically exited unprofitable channels and customers.
Risk or Challenges
Strategic Exits: The company strategically exited unprofitable channels and customers, which may pose risks of short-term revenue decline as they adjust their business model.
Regulatory Risks: The acquisition of SRx Health may involve regulatory scrutiny and compliance challenges, which could impact the timeline and success of the integration.
Market Competition: The pet food market is experiencing rapid growth, but increased competition from other brands could pressure market share and profitability.
Economic Factors: The company is exposed to economic fluctuations that could affect consumer spending on pet products, particularly in international markets.
Operational Efficiency: While operational improvements have been made, there is a risk that the anticipated operational efficiencies and synergies from the SRx Health acquisition may not materialize as expected.
Supply Chain Challenges: The company has improved fill rates and inventory management, but ongoing supply chain disruptions could impact future performance.
Guidance & Outlook
Strategic Pivots: The company has made strategic pivots to improve operational consistency and executional discipline, leading to improved margins and a reset for sustained profitable growth.
Acquisition of SRx Health: Better Choice is in the process of acquiring SRx Health, which is expected to yield operational efficiencies and synergies, driving sustainable organic growth.
International Growth Opportunities: The company sees significant growth potential in the Asia-Pacific region, particularly in China, where the pet food market is rapidly expanding.
Revenue Growth Expectations: The company generated $11.4 million in sales for Q3 2024, with a 33% quarter-over-quarter growth and expects continued growth in both domestic and international markets.
Profitability Goals: The objective for 2024 is to step change profitability, generate cash, and create a long-term strategy for disciplined growth.
Adjusted EBITDA: The company achieved its first profitable quarter in years with adjusted EBITDA just over $200,000, indicating a positive trend in financial performance.
Future Financial Projections: The company is confident in its ability to deliver on near- and long-term goals, with expectations for continued upward trajectory into 2025.
Shareholder Return Plan
Net Income: $1.5 million for the third quarter.
Earnings Per Share: $0.74 for the third quarter.
Adjusted EBITDA: Just over $200,000, marking the first profitable quarter in over four years.
Free Cash Flow: Improved free cash flow reported.
Net Working Capital Position: $9.5 million, compared to $3.1 million last quarter.
Public Offering Proceeds: Raised just under $5 million in net proceeds.
Key Q&A
Earnings Word Cloud
BTTR Transcript
The earnings call revealed strong financial performance with significant revenue growth and improved profit margins. Despite a slight annual revenue decline due to strategic changes, the company showed improved debt management and operational efficiency. The acquisition plans and royalty distribution indicate positive shareholder returns. Although there are risks, the overall sentiment is positive, supported by strategic initiatives and a focus on long-term growth. The lack of analyst questions during the Q&A session suggests no immediate concerns.
The earnings call shows positive financial performance, with significant revenue growth and improved EBITDA. Strategic initiatives like the acquisition of SRx Health and a royalty distribution plan are expected to drive future growth. Despite some risks, the overall sentiment is positive, especially with improved margins and shareholder returns. The lack of questions in the Q&A suggests no major concerns from analysts.
The earnings call summary highlights strong financial performance, including significant sales growth and a positive adjusted EBITDA for the first time in years. Strategic initiatives such as the acquisition of SRx Health and operational improvements are expected to drive future growth. Despite competitive pressures and regulatory risks, the company's focus on profitability and cash generation is promising. The lack of significant concerns in the Q&A session further supports a positive sentiment. The recent public offering may slightly temper the reaction, but overall, a positive stock price movement is anticipated.
BTTR Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
